These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17204619)

  • 1. Biomedicine. Puzzling out the pains in the gut.
    Marx J
    Science; 2007 Jan; 315(5808):33-5. PubMed ID: 17204619
    [No Abstract]   [Full Text] [Related]  

  • 2. T helper 17 cells get the NOD.
    Stetson DB; Medzhitov R
    Immunity; 2007 Oct; 27(4):546-8. PubMed ID: 17967409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
    Rogler G
    Gut; 2010 Feb; 59(2):153-4. PubMed ID: 20176638
    [No Abstract]   [Full Text] [Related]  

  • 4. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease.
    Gewirtz AT; Vijay-Kumar M; Brant SR; Duerr RH; Nicolae DL; Cho JH
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1157-63. PubMed ID: 16439468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLRs in the Gut. III. Immune responses to flagellin in Crohn's disease: good, bad, or irrelevant?
    Gewirtz AT
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G706-10. PubMed ID: 17038626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gammadelta T cell receptors without a job.
    Kapsenberg ML
    Immunity; 2009 Aug; 31(2):181-3. PubMed ID: 19699169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
    Devlin SM; Yang H; Ippoliti A; Taylor KD; Landers CJ; Su X; Abreu MT; Papadakis KA; Vasiliauskas EA; Melmed GY; Fleshner PR; Mei L; Rotter JI; Targan SR
    Gastroenterology; 2007 Feb; 132(2):576-86. PubMed ID: 17258734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
    Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Brand S
    Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The link between IL-23 and Th17 cell-mediated immune pathologies.
    McGeachy MJ; Cua DJ
    Semin Immunol; 2007 Dec; 19(6):372-6. PubMed ID: 18319054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease.
    Hanauer SB; Hommes DW
    Expert Rev Clin Immunol; 2010 Jul; 6(4):499-500. PubMed ID: 20594118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The innate immune system and inflammatory bowel disease.
    Davies JM; Abreu MT
    Scand J Gastroenterol; 2015 Jan; 50(1):24-33. PubMed ID: 25523553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.
    Ferwerda G; Kullberg BJ; de Jong DJ; Girardin SE; Langenberg DM; van Crevel R; Ottenhoff TH; Van der Meer JW; Netea MG
    J Leukoc Biol; 2007 Oct; 82(4):1011-8. PubMed ID: 17652449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired innate immunity in Crohn's disease.
    Comalada M; Peppelenbosch MP
    Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.